Time To Inject Some Contrast into the Nephrotoxicity Debate

Area of Science:

• Nephrology
• Radiology
• Clinical Trials

Background:

• Historically, iodinated contrast media were associated with contrast-induced AKI (CI-AKI), particularly high-osmolar agents.
• Early studies linking contrast media to kidney damage were often confounded by patient comorbidities and procedural risks.

Purpose of the Study:

• To evaluate the contemporary risk of CI-AKI with modern low- and iso-osmolar contrast agents.
• To assess the efficacy of preventive strategies and address the clinical impact of exaggerated fears of CI-AKI.

Main Methods:

• Review of contemporary propensity-matched and controlled analyses.
• Analysis of large randomized trials, such as the PRESERVE trial, evaluating hydration and N-acetylcysteine.
• Examination of clinical outcomes in high-risk populations (CKD, AKI, critical illness).

Main Results:

• Modern low- and iso-osmolar contrast agents uncommonly cause true nephrotoxicity, even in high-risk patients.
• Preventive strategies like sodium bicarbonate, saline hydration, and N-acetylcysteine showed no significant outcome benefit in large trials.
• Risks such as fluid overload were highlighted in preventive strategy trials.

Conclusions:

• The persistent fear of CI-AKI, termed 'renalism,' can lead to delayed or avoided essential imaging, negatively impacting patient outcomes.
• Current evidence supports an individualized approach, focusing on avoiding hypovolemia, limiting contrast dose, and withholding nephrotoxins only in severe kidney impairment.
• A balanced, evidence-based strategy should supersede outdated caution regarding contrast media use.